Samyr is an ademetionine-based medication supplied as gastro-resistant tablets. The product is commonly used in clinical practice to support liver function and metabolic processes.
The medication is available in two strengths:
The gastro-resistant tablet coating helps protect the active ingredient and supports its release in the intestinal tract.
SAMYR is manufactured by Viatris (Italy) and is commonly included in comprehensive therapy programs related to liver function and metabolic support.
Samyr may be recommended in cases involving:
The medication should be used according to healthcare professional recommendations.
Ademetionine is a biologically active compound involved in important biochemical reactions, including methylation processes and synthesis of functional molecules.
Samyr is used to support metabolic activity and liver function.
The gastro-resistant formulation helps preserve active ingredient stability before intestinal release.
The tablets should be taken orally according to medical advice or product instructions.
Dosage and treatment duration are determined individually.
The tablets should be swallowed whole without chewing.
Some individuals may experience:
Medical attention should be sought if side effects occur.
Samyr should not be used in patients with hypersensitivity to its ingredients.
Consultation with a healthcare professional is recommended before use during pregnancy, breastfeeding, or chronic illness.
SAMYR is an ademetionine-based gastro-resistant tablet medication.
The main difference is the dosage strength of ademetionine.
The product is commonly used to support liver function and metabolic processes.
The tablets should be taken orally according to healthcare professional recommendations.
Gastro-resistant tablets should generally be swallowed whole.
A standard package contains 20 tablets.
Ask a question or inquire about delivery to your country
